Neutra Corporation (NTRR) financial statements (2022 and earlier)
Company profile
| Business Address |
54 SUGAR CREEK CENTER BLVD. SUGAR LAND, TX 77478 |
| State of Incorp. | WY |
| Fiscal Year End | January 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 10/31/2020 TTM | 1/31/2020 | 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 177 | 0 | 7 | ||||||
| Cash and cash equivalents | 177 | 0 | 7 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 4 | ||||||||
| Inventory | 4 | ||||||||
| Other undisclosed current assets | 2 | 164 | 12 | ||||||
| Total current assets: | 182 | 164 | 12 | 0 | 7 | ||||
| Noncurrent Assets | |||||||||
| TOTAL ASSETS: | 182 | 164 | 12 | 0 | 7 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 411 | 458 | 458 | 471 | 391 | 334 | |||
| Interest and dividends payable | 174 | 134 | 55 | 14 | 0 | ||||
| Other undisclosed accounts payable and accrued liabilities | 237 | 324 | 403 | 458 | 391 | 334 | |||
| Debt | 23 | 62 | 147 | 56 | 6 | ||||
| Due to related parties | 132 | 84 | 84 | 84 | 7 | ||||
| Other undisclosed current liabilities | 466 | 665 | 59 | 17 | 0 | ||||
| Total current liabilities: | 1,032 | 1,269 | 748 | 628 | 398 | 341 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 17 | 29 | 18 | 46 | |||||
| Long-term debt, excluding current maturities | 17 | 29 | 18 | 46 | |||||
| Liabilities, other than long-term debt | 12 | 19 | 11 | 6 | |||||
| Accounts payable and accrued liabilities | 12 | 19 | 11 | 6 | |||||
| Total noncurrent liabilities: | 29 | 47 | 28 | 52 | |||||
| Total liabilities: | 1,032 | 1,269 | 777 | 676 | 426 | 393 | |||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (849) | (1,106) | (764) | (676) | (425) | (386) | |||
| Preferred stock | 1 | 1 | 1 | 1 | |||||
| Common stock | 616 | 34 | 7 | 3 | 2 | ||||
| Additional paid in capital | 8,092 | 7,723 | 5,662 | 5,236 | 4,619 | 3,154 | |||
| Accumulated deficit | (9,559) | (8,864) | (6,434) | (5,915) | (5,047) | (3,605) | |||
| Other additional capital | 60 | ||||||||
| Other undisclosed stockholders' equity attributable to parent | 2 | 5 | |||||||
| Total stockholders' equity: | (849) | (1,106) | (764) | (676) | (425) | (386) | |||
| TOTAL LIABILITIES AND EQUITY: | 182 | 164 | 12 | 0 | 7 | ||||
Income statement (P&L) ($ in thousands)
| 10/31/2020 TTM | 1/31/2020 | 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Other income | 1 | ✕ | ||||||
| Gross profit: | 6 | 1 | ||||||
| Operating expenses | (401) | (1,709) | (164) | (371) | (1,036) | (636) | ||
| Other undisclosed operating loss | (1) | |||||||
| Operating loss: | (394) | (1,709) | (164) | (371) | (1,036) | (636) | ||
| Nonoperating expense | (301) | (720) | (355) | (497) | (407) | |||
| Interest and debt expense | 74 | (721) | (355) | (497) | (402) | (1,151) | ||
| Net loss: | (621) | (3,150) | (874) | (1,365) | (1,844) | (1,787) | ||
| Other undisclosed net income (loss) attributable to parent | (74) | 721 | 355 | 497 | 402 | (110) | ||
| Net loss available to common stockholders, diluted: | (696) | (2,429) | (519) | (868) | (1,443) | (1,897) | ||
Comprehensive Income ($ in thousands)
| 10/31/2020 TTM | 1/31/2020 | 1/31/2019 | 1/31/2018 | 1/31/2017 | 1/31/2016 | 1/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (621) | (3,150) | (874) | (1,365) | (1,844) | (1,787) | ||
| Comprehensive loss, net of tax, attributable to parent: | (621) | (3,150) | (874) | (1,365) | (1,844) | (1,787) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.